Tharimmune Inc. (THAR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tharimmune Inc. (THAR) has a cash flow conversion efficiency ratio of -0.301x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.86 Million) by net assets ($6.15 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tharimmune Inc. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Tharimmune Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Tharimmune Inc. (THAR) financial obligations for a breakdown of total debt and financial obligations.
Tharimmune Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tharimmune Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Coda Octopus Group Inc
NASDAQ:CODA
|
0.025x |
|
Kenorland Minerals Ltd
V:KLD
|
-0.007x |
|
Amir Marketing and Investments in Agriculture Ltd
TA:AMRK
|
-0.002x |
|
DEEZER S.A. EO 1
F:L0A
|
N/A |
|
Hooker Furniture Corporation
NASDAQ:HOFT
|
0.028x |
|
Shanghai Jinjiang International Travel Co Ltd
SHG:900929
|
-0.018x |
|
Companhia Estadual de Distribuição de Energia Elétrica
SA:CEED3
|
0.095x |
|
Horizon Copper Corp.
V:HCU
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Tharimmune Inc. (2019–2024)
The table below shows the annual cash flow conversion efficiency of Tharimmune Inc. from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see THAR stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.31 Million | $-10.90 Million | -8.337x | -942.85% |
| 2023-12-31 | $9.13 Million | $-7.30 Million | -0.799x | +32.42% |
| 2022-12-31 | $5.54 Million | $-6.56 Million | -1.183x | -610.21% |
| 2021-12-31 | $-4.68 Million | $-1.09 Million | 0.232x | -20.07% |
| 2020-12-31 | $-3.72 Million | $-1.08 Million | 0.290x | -33.35% |
| 2019-12-31 | $-1.62 Million | $-706.11K | 0.435x | -- |
About Tharimmune Inc.
Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. w… Read more